Results 291 to 300 of about 59,693 (345)

Optimizing Nephron Performance: The Old, the New, and the New-Old Diuretic Therapies. [PDF]

Biomedicines
Fuchs FD, Procianoy GS, Bottino LG, Fuchs SC, Whelton PK.   +4 more
europepmc   +1 more source

Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure

, 2002
Mariantonietta Cicoira, Luisa Zanolla, Andrea Rossi, Giorgio Golia, Lorenzo Franceschini, Giovanna Brighetti, Paolo Marino, Piero Zardini   +7 more
openalex   +1 more source

Rare Case of Adult-Onset Gitelman Syndrome in a Patient With Multiple Comorbidities: A Case Report. [PDF]

Clin Case Rep
Hussen MD, Rezwana F, Ony MI, Sultana F, Joba FA, Tabassum Z.   +5 more
europepmc   +1 more source

Relative Long-Term Effects of Spironolactone in Conjunction with an Angiotensin-Converting Enzyme Inhibitor on Left Ventricular Mass and Diastolic Function in Patients with Essential Hypertension.

, 2002
Atsuhisa Sato, Matsuhiko Hayashi, Takao Saruta   +2 more
openalex   +2 more sources

Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment. [PDF]

Dermatol Pract Concept
Al Sayed NM, El Morsy EH, Hussein TM, Hassan EM.   +3 more
europepmc   +1 more source

Gitelman syndrome with hypercalcemia and normomagnesemia: A case report. [PDF]

Medicine (Baltimore)
Tan Z, Liu C, Feng Z, Luo Z, Lian X, Lu D.   +5 more
europepmc   +1 more source

Sudden Collapse in a Child Revealing a Malignant Coronary Anomaly: A Case of Congenital Anomaly of Left Coronary Artery Origin. [PDF]

Cureus
Imran A, Carter H, Mensah J, Ahmed M, Solano J.   +4 more
europepmc   +1 more source

Dose-exposure-response of CARDALIS® (benazepril/spironolactone) on the classical and alternative arms of the renin-angiotensin-aldosterone system in healthy dogs. [PDF]

J Vet Intern Med
Manson E, Ward JL, Merodio M, Guillot E, Blondel T, Allenspach K, Domenig O, Mochel JP.   +7 more
europepmc   +1 more source

Finerenone: a breakthrough mineralocorticoid receptor antagonist for heart failure, diabetes and chronic kidney disease. [PDF]

Egypt Heart J
Pradhan A, Tripathi UC.
europepmc   +1 more source

Recent Advances and Perspectives on the Use of Mineralocorticoid Receptor Antagonists for the Treatment of Hypertension and Chronic Kidney Disease: A Review. [PDF]

Biomedicines
Miyasako K, Maeoka Y, Masaki T.
europepmc   +1 more source